A new drug shows preclinical efficacy in Rett syndrome

(IDIBELL-Bellvitge Biomedical Research Institute) A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome in preclinical models.
Source: EurekAlert! - Biology - Category: Biology Source Type: news